It has previously been sold in the USA and approval has been withdrawn in 2005 due to safety reasons.
I have heard the dosages currently delivered are different to those in use at the time in the US and do not show the same problems.
I expect the bureaucrats in the FDA to play it safe and require plenty of further evidence to show the same issues are not still present.
Patience is required with this stock, imo. I have an investment which I am happy to leave on the table for the medium term, ignoring any short term market fluctuations.
Annual report, page-21
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
-0.015(3.19%) |
Mkt cap ! $47.52M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 47.5¢ | 45.5¢ | $98.40K | 210.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12936 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 649 | 1 |
View Market Depth
| Last trade - 15.47pm 15/08/2024 (20 minute delay) ? |
| MVP (ASX) Chart |